Neuron derived neurotrophic factor
Appearance
Neuron derived neurotrophic factor (NDNF) is a secreted protein that, in humans, is located on chromosome 4.[5] This protein helps in the growth, survival, migration, and differentiation of neurons.[6] To assist with migration, NDNF shows neuro-repulsive effects on GnRH neurons. Loss of function (LoF) in the NDNF gene has been shown to be a cause of a disease known as congenital hypogonadotropic hypogonadism, which can have associated cleft lip and cleft palate.[7] A preliminary study has shown that knock-down of ndnf reduces development of the ethmoid plate, which is homologous to the human palate.[8][9]
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000173376 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000049001 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "NDNF neuron derived neurotrophic factor [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2023-05-12.
- ^ Kuang XL, Zhao XM, Xu HF, Shi YY, Deng JB, Sun GT (October 2010). "Spatio-temporal expression of a novel neuron-derived neurotrophic factor (NDNF) in mouse brains during development". BMC Neuroscience. 11 (1): 137. doi:10.1186/1471-2202-11-137. PMC 2984559. PMID 20969804.
- ^ Messina A, Pulli K, Santini S, Acierno J, Känsäkoski J, Cassatella D, et al. (January 2020). "Neuron-Derived Neurotrophic Factor Is Mutated in Congenital Hypogonadotropic Hypogonadism". American Journal of Human Genetics. 106 (1): 58–70. doi:10.1016/j.ajhg.2019.12.003. PMC 7042563. PMID 31883645.
- ^ Swartz ME, Sheehan-Rooney K, Dixon MJ, Eberhart JK (September 2011). "Examination of a palatogenic gene program in zebrafish". Developmental Dynamics. 240 (9): 2204–2220. doi:10.1002/dvdy.22713. PMC 3202344. PMID 22016187.
- ^ Melvin VS, Feng W, Hernandez-Lagunas L, Artinger KB, Williams T (July 2013). "A morpholino-based screen to identify novel genes involved in craniofacial morphogenesis". Developmental Dynamics. 242 (7): 817–831. doi:10.1002/dvdy.23969. PMC 4027977. PMID 23559552.
Further reading
[edit]- Utine GE, Aktas D (2006). "Mosaicism for terminal deletion of 4q". Genetic Counseling. 17 (2): 205–209. PMID 16970039.
- Kalsi G, Kuo PH, Aliev F, Alexander J, McMichael O, Patterson DG, et al. (June 2010). "A systematic gene-based screen of chr4q22-q32 identifies association of a novel susceptibility gene, DKK2, with the quantitative trait of alcohol dependence symptom counts". Human Molecular Genetics. 19 (12): 2497–2506. doi:10.1093/hmg/ddq112. PMC 2876884. PMID 20332099.
- Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR (2010). "Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score". Molecular Medicine. 16 (7–8): 247–253. doi:10.2119/molmed.2009.00159. PMC 2896464. PMID 20379614.